In the last trading session, 2.23 million Mind Medicine Inc (NASDAQ:MNMD) shares changed hands as the company’s beta touched 1.77. With the company’s per share price at $7.63 changed hands at -$0.55 or -6.72% during last session, the market valuation stood at $559.52M. MNMD’s last price was a discount, traded about -60.16% off its 52-week high of $12.22. The share price had its 52-week low at $4.50, which suggests the last value was 41.02% up since then.
Analysts gave the Mind Medicine Inc (MNMD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.10. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended MNMD as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Mind Medicine Inc’s EPS for the current quarter is expected to be -0.28.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD was in red as seen at the end of in last trading. With action -11.79%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 9.63%, with the 5-day performance at -11.79% in the red. However, in the 30-day time frame, Mind Medicine Inc (NASDAQ:MNMD) is 8.92% up.
The consensus price target for the stock as assigned by Wall Street analysts is 14, meaning bulls need an upside of 45.5% from its current market value. According to analyst projections, MNMD’s forecast low is 14 with 14 as the target high. To hit the forecast high, the stock’s price needs a -83.49% plunge from its current level, while the stock would need to soar -83.49% for it to hit the projected low.
Mind Medicine Inc (MNMD) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 2.29%. The 2025 estimates are for Mind Medicine Inc earnings to increase by 41.32%, but the outlook for the next 5-year period is at 14.93% per year.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Among Mutual Funds, the top two as of Nov 30, 2024 were iShares Russell 2000 ETF and Vanguard Extended Market Index Fund. With 2.03 shares estimated at $15.49 million under it, the former controlled 2.77% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.43% of the shares, roughly 1.05 shares worth around $8.02 million.
